Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib.

[1]  M. Lebwohl,et al.  Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways , 2020 .

[2]  B. King,et al.  Treatment of granuloma annulare with tofacitinib 2% ointment , 2019, JAAD case reports.

[3]  B. King,et al.  Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare. , 2020, Journal of the American Academy of Dermatology.

[4]  C. Richards,et al.  Oncostatin M in the Regulation of Connective Tissue Cells and Macrophages in Pulmonary Disease , 2019, Biomedicines.

[5]  J. English,et al.  Immune checkpoint inhibitors and the development of granulomatous reactions. , 2019, Journal of the American Academy of Dermatology.

[6]  M. Rosenbach,et al.  Granuloma annulare: a retrospective series of 133 patients. , 2019, Cutis.

[7]  J. Alonso,et al.  Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression , 2018, Front. Oncol..

[8]  R. Clark,et al.  Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing &agr;&bgr; T cell clones , 2017, The Journal of clinical investigation.

[9]  Alicia J. Zollinger,et al.  Fibronectin, the extracellular glue. , 2017, Matrix biology : journal of the International Society for Matrix Biology.

[10]  M. Rosenbach,et al.  Antimalarial therapy for granuloma annulare: Results of a retrospective analysis , 2017, Journal of the American Academy of Dermatology.

[11]  N. Huntington,et al.  IL-15 signaling in NK cell cancer immunotherapy. , 2017, Current opinion in immunology.

[12]  M. Sundaram,et al.  Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor‐&agr; inhibitors versus methotrexate , 2017, Journal of the American Academy of Dermatology.

[13]  P. Murray Macrophage Polarization. , 2017, Annual review of physiology.

[14]  M. Rosenbach,et al.  Granuloma annulare: Clinical and histologic variants, epidemiology, and genetics. , 2016, Journal of the American Academy of Dermatology.

[15]  M. Rosenbach,et al.  Granuloma annulare: Pathogenesis, disease associations and triggers, and therapeutic options. , 2016, Journal of the American Academy of Dermatology.

[16]  W. Leonard,et al.  IL-21 Signaling in Immunity , 2016, F1000Research.

[17]  Janne Kutschera Sund,et al.  Medication reconciliation of patients with hip fracture by clinical pharmacists , 2015, European journal of hospital pharmacy. Science and practice.

[18]  F. Vezzi,et al.  T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis , 2015, European Respiratory Journal.

[19]  Chun-Yin Huang,et al.  Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy , 2015, The Journal of Immunology.

[20]  R. Markwald,et al.  The role of periostin in tissue remodeling across health and disease , 2013, Cellular and Molecular Life Sciences.

[21]  J. English,et al.  Etiology, Diagnosis, and Therapeutic Management of Granuloma Annulare: An Update , 2013, American Journal of Clinical Dermatology.

[22]  L. Skov,et al.  Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti‐inflammatory drugs: a Danish real‐world cohort study , 2013, Journal of internal medicine.

[23]  J. Curtsinger,et al.  Autocrine IFN-γ Promotes Naive CD8 T Cell Differentiation and Synergizes with IFN-α To Stimulate Strong Function , 2012, The Journal of Immunology.

[24]  P. Iversen,et al.  Interstitial fluid: the overlooked component of the tumor microenvironment? , 2010, Fibrogenesis & tissue repair.

[25]  H. Rammensee,et al.  Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. , 2009, Clinical immunology.

[26]  Daniel R. Beisner,et al.  Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor , 2009, Nature Immunology.

[27]  A. Drosos,et al.  Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors , 2009, Scandinavian journal of rheumatology.

[28]  K. Stefanaki,et al.  Histological and immunohistochemical study of granuloma annulare and subcutaneous granuloma annulare in children , 2007, Journal of cutaneous pathology.

[29]  Daniel B. Shin,et al.  Risk of myocardial infarction in patients with psoriasis. , 2006, JAMA.

[30]  R. Kirsner,et al.  Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. , 2005, Journal of the American Academy of Dermatology.

[31]  B. Cribier [Granuloma annulare]. , 2005, Annales de dermatologie et de venereologie.

[32]  A. Miyajima,et al.  Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice , 2004, Hepatology.

[33]  J. Ring,et al.  T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation. , 2002, The Journal of investigative dermatology.

[34]  M. Noda,et al.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. , 2001, The Journal of clinical investigation.

[35]  D. Gemsa,et al.  Increase of CCR1 and CCR5 expression and enhanced functional response to MIP‐1α during differentiation of human monocytes to macrophages , 2001, Journal of leukocyte biology.

[36]  E. Coles,et al.  The effect of severe psoriasis on the quality of life of 369 patients , 1995, The British journal of dermatology.

[37]  M. Kallioinen,et al.  Biochemical and immunohistochemical comparison of collagen in granuloma annulare and skin sarcoidosis. , 1989, Acta dermato-venereologica.

[38]  S. Barter,et al.  Increased plasma fibronectin in diabetes mellitus, necrobiosis lipoidica and widespread granuloma annulare , 1984, Clinical and experimental dermatology.

[39]  F. Grinnell Fibronectin and wound healing , 1984, Journal of cellular biochemistry.

[40]  R. Friedman‐Birnbaum,et al.  Histocompatibility antigens in granuloma annulare , 1978, The British journal of dermatology.